AUS
NZ
UK
CA
USA
IND
Health
How Did Waters Co. (NYSE:WAT) Exceed Earnings Expectations This Quarter
February 13, 2025 09:27 AM PST| By Team Kalkine MediaHighlights,Waters Co. saw a 4% increase in trading volume after its earnings report.,The company posted earnings of $4.10 per share, surpassing estimates.,Institutional investors raised their stakes in Waters Co. following the earnings release.,Water...
How Is Walgreens Boots Alliance (NASDAQ:WBA) Navigating Market Volatility
February 13, 2025 09:14 AM PST| By Team Kalkine MediaHighlights,Sumitomo Mitsui Trust Group Inc. reduced its stake in Walgreens Boots Alliance during the fourth quarter.,Market perspectives on Walgreens Boots Alliance vary, with updates from financial entities.,The company reported a revenue increase,...
How Is AbbVie Inc. (NYSE:ABBV) Positioned in the Pharmaceutical Market
February 13, 2025 09:10 AM PST| By Team Kalkine MediaHighlights,Institutional firms have significantly increased holdings in AbbVie, with notable acquisitions.,Stock performance reflects fluctuations in earnings and market valuation.,AbbVie remains a key player in pharmaceuticals with a broad product p...
How Are Market Fluctuations Impacting Illumina (NASDAQ:ILMN)
February 13, 2025 09:08 AM PST| By Team Kalkine MediaHighlights,Financial firms have revised expectations for Illumina, adjusting stock ratings and target prices.,The company's stock has exhibited fluctuations, influencing market sentiment.,Institutional investors have modified their holdings, reflecti...
How Are Market Trends Impacting Charles River Laboratories (NYSE:CRL) Stock Performance
February 13, 2025 08:33 AM PST| By Team Kalkine MediaHighlights,Institutional investors, including Mirae Asset Global Investments Co. Ltd., have increased their holdings in Charles River Laboratories.,Stock performance has declined, with financial indicators reflecting market volatility.,Analysts have...
How Are Institutional Investors Adjusting Their Holdings in Axsome Therapeutics (NASDAQ:AXSM)
February 13, 2025 08:28 AM PST| By Team Kalkine MediaHighlights,Multiple financial firms have provided positive ratings for Axsome Therapeutics, reflecting confidence in the company’s direction.,The company’s stock has experienced notable gains, backed by increasing institutional participation.,Axsome’...
Is Merus NV (NASDAQ:MRUS) Expanding Its Presence in Antibody Therapeutics?
February 13, 2025 08:26 AM PST| By Team Kalkine MediaHighlights,Market firms have issued varied perspectives on Merus NV, with multiple evaluations reflecting different expectations.,The company focuses on bispecific antibody therapeutics, targeting oncology and solid tumor treatments.,Institutional ho...
Is Henry Schein (NASDAQ:HSIC) Gaining Institutional Attention Amid Market Stability?
February 13, 2025 08:21 AM PST| By Team Kalkine MediaHighlights,Institutional investors, including Sumitomo Mitsui Trust Group, have adjusted their holdings in Henry Schein.,The stock maintains a steady market presence, with financial metrics reflecting stability.,Analysts present varied ratings, with...
How Has Myriad Genetics (NASDAQ:MYGN) Performed Amid Market Fluctuations
February 13, 2025 08:20 AM PST| By Team Kalkine MediaHighlights,Institutional investors adjusted their holdings in Myriad Genetics, signaling market engagement.,The company’s stock performance has fluctuated within a wide range over the past year.,Myriad Genetics specializes in genetic testing, with a...
How Is Q32 Bio (NASDAQ:QTTB) Navigating Market Volatility
February 13, 2025 08:16 AM PST| By Team Kalkine MediaHighlights,Institutional investors have adjusted their positions in Q32 Bio, with notable stake increases in recent months.,Stock fluctuations have led to revised ratings from financial firms, reflecting changes in market sentiment.,The company conti...
How Has Nurix Therapeutics (NASDAQ:NRIX) Performed Amid Market Volatility
February 13, 2025 08:15 AM PST| By Team Kalkine MediaHighlights,Sumitomo Mitsui Trust Group Inc. increased its holdings in Nurix Therapeutics by 42.7% in Q4.,Various firms have revised their projections, reflecting increased attention on the stock.,The company is advancing its pipeline of treatments fo...
Why Has the State of Alaska Department of Revenue Adjusted Its Holdings in Encompass Health?
February 13, 2025 02:25 AM PST| By Team Kalkine MediaHighlights,The State of Alaska Department of Revenue reduced its stake in Encompass Health Co.,(NYSE:EHC),during the fourth quarter.,Institutional investors, including MassMutual Private Wealth & Trust FSB and UMB Bank n.a., have adjusted their holdi...
Why Is STERIS plc (NYSE:STE) Attracting Institutional Attention?
February 13, 2025 02:02 AM PST| By Team Kalkine MediaHighlights,Institutional investors continue adjusting their holdings in STERIS plc,(NYSE:STE),, reflecting ongoing interest in the medical equipment sector.,Several firms have increased their positions in STERIS, contributing to shifts in ownership s...
Is UnitedHealth Group (NYSE:UNH) Drawing Attention with Recent Acquisition?
February 13, 2025 01:57 AM PST| By Team Kalkine MediaHeadlines,Representative Gilbert Ray Cisneros, Jr. recently disclosed the purchase of shares in UnitedHealth Group.,The transaction, reported on February 11, involved a value between $15,001 and $50,000.,UnitedHealth Group’s Position in the Healthcar...
Danaher Corporation Strategic Capital Reconfigurations and Market Performance (NYSE:DHR)
February 13, 2025 01:47 AM PST| By Team Kalkine MediaDanaher Corporation Strategic Capital Reconfigurations and Market Performance (NYSE:DHR)
Why Is CVS Health (NYSE:CVS) Gaining Attention in the Healthcare Sector?
February 13, 2025 01:05 AM PST| By Team Kalkine MediaHighlights,CVS Health has been a key player in the healthcare sector, operating a large pharmacy network and health insurance services.,The company has been involved in strategic expansions, acquisitions, and operational improvements to strengthen it...
Is CVS Health (NYSE:CVS) Facing Challenges Amid Changing Industry Trends?
February 13, 2025 01:00 AM PST| By Team Kalkine MediaHighlights,CVS Health,(NYSE:CVS),has seen fluctuations in its valuation amid evolving industry dynamics.,The company has been adjusting its business strategies to maintain its standing in the healthcare sector.,Several industry reports have provided...
Aardvark Therapeutics (Nasdaq: AARD) Prices Initial Public Offering to Raise $94.2Mn
February 13, 2025 12:42 AM PST| By Team Kalkine MediaHighlights,Aardvark Therapeutics sets IPO price at $16.00 per share, aiming to raise $94.2 million.,Company will trade on Nasdaq Global Select Market under ticker symbol 'AARD' starting February 13, 2025.,Strong underwriting syndicate led by Morgan S...
atai Life Sciences (NASDAQ: ATAI) Announces Pricing of $55 Million Public Offering
February 13, 2025 12:40 AM PST| By Team Kalkine MediaHighlights,atai Life Sciences to raise approximately $55 million through a public offering of 26.19 million shares.,Offering proceeds will support clinical development and general corporate purposes.,Berenberg acts as the sole bookrunner for the offe...
Why Did Edwards Lifesciences (NYSE:EW) Surge After Earnings Report?
February 13, 2025 12:38 AM PST| By Team Kalkine MediaHighlights,Edwards Lifesciences saw its stock price rise after reporting earnings that exceeded expectations.,The company posted a net margin of 70.82% and a return on equity of 20.76%.,Recent financial results have generated increased interest in th...
